E-M Muchitsch - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

E-M Muchitsch

Showing results (11-20 of 16) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 16 results.

Journal of Thrombosis and Haemostasis : JTH|May 9, 2009

Species-dependent variability of ADAMTS13-mediated proteolysis of human recombinant von Willebrand factorK Varadi, H Rottensteiner, S Vejda, et al.

Vox Sanguinis|October 16, 2010

Biochemical, molecular and preclinical characterization of a double-virus-reduced human butyrylcholinesterase preparation designed for clinical useA Weber, H Butterweck, U Mais-Paul, et al.

Journal of Thrombosis and Haemostasis : JTH|July 3, 2016

Preclinical assessment of a new recombinant ADAMTS-13 drug product (BAX930) for the treatment of thrombotic thrombocytopenic purpuraA Kopić, K Benamara, C Piskernik, et al.

Haemophilia : the Official Journal of the World Federation of Hemophilia|June 12, 2010

Modulation of factor VIII-specific memory B cellsB M Reipert, P Allacher, C Hausl, et al.

Hamostaseologie|September 19, 2009

Development of a plasma- and albumin-free recombinant von Willebrand factorP L Turecek, A Mitterer, H P Matthiessen, et al.

Hamostaseologie|September 11, 2012

BAX 855, a PEGylated rFVIII product with prolonged half-life. Development, functional and structural characterisationP L Turecek, M J Bossard, M Graninger, et al.

Pageof 2

Search research articles

Showing results (11-20 of 16) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 16 results.

Journal of Thrombosis and Haemostasis : JTH|May 9, 2009

Species-dependent variability of ADAMTS13-mediated proteolysis of human recombinant von Willebrand factorK Varadi, H Rottensteiner, S Vejda, et al.

Vox Sanguinis|October 16, 2010

Biochemical, molecular and preclinical characterization of a double-virus-reduced human butyrylcholinesterase preparation designed for clinical useA Weber, H Butterweck, U Mais-Paul, et al.

Journal of Thrombosis and Haemostasis : JTH|July 3, 2016

Preclinical assessment of a new recombinant ADAMTS-13 drug product (BAX930) for the treatment of thrombotic thrombocytopenic purpuraA Kopić, K Benamara, C Piskernik, et al.

Haemophilia : the Official Journal of the World Federation of Hemophilia|June 12, 2010

Modulation of factor VIII-specific memory B cellsB M Reipert, P Allacher, C Hausl, et al.

Hamostaseologie|September 19, 2009

Development of a plasma- and albumin-free recombinant von Willebrand factorP L Turecek, A Mitterer, H P Matthiessen, et al.

Hamostaseologie|September 11, 2012

BAX 855, a PEGylated rFVIII product with prolonged half-life. Development, functional and structural characterisationP L Turecek, M J Bossard, M Graninger, et al.

Pageof 2